Download MicroScan Gram Positive MIC Panel

M ORE CHOICES
MORE ANSWERS
MICROSCAN GRAM POSITIVE CONVENTIONAL MIC PANELS
Combating antibiotic-resistant bacteria:
the Microbiology lab answers the challenge
There has been an alarming increase in antibiotic-resistant infections, both in the United States and
worldwide. Methicillin-resistant Staphylococcus aureus (MRSA) outbreaks have been reported by
the media for more than a decade. In early 2015, a presidential task force released the National
Action Plan for Combating Antibiotic Resistant Bacteria. The goals and strategies outlined in this
document are intended to significantly reduce the incidence of urgent and serious threats, including
MRSA, by 2020.
New! Ceftaroline and Tigecycline now available
MicroScan is the first to offer ceftaroline on an automated susceptibility panel. Unlike most previous
cephems, ceftaroline† is able to bind to and inhibit altered penicillin-binding proteins associated with
resistance to ß-lactam drugs, making it the first drug in its class approved for treatment of MRSA in
acute bacterial skin and skin structure infections (ABSSSI). Tigecycline‡, a glycycline antibiotic, is not
affected by the two major in-class resistance mechanisms, ribosomal protection and efflux, and has
demonstrated activity against a broad spectrum of bacterial pathogens including MRSA. Including these
advanced-generation antibiotics can augment your testing menu and help improve workflow efficiency in
your laboratory by:
» Expanding your capabilities for treating MRSA
» Enhancing your microbiology testing menu
» Reducing supplemental testing costs
MicroScan MIC Panels
For over 30 years, MicroScan panels have provided gold-standard bacterial
identification and susceptibility products, confronting emerging resistance
with first time results and accuracy. The first vancomycin-intermediate and
vancomycin-resistant Staphylococcus aureus isolates were detected during
routine testing on MicroScan Systems.1, 2 Now with the adoption of MALDI
technologies, there is even more interest in complementary MIC panel
options. Integration of rapid MALDI-TOF identifications with the accuracy
of MicroScan MIC results, provide best-in-class technologies to support
antimicrobial stewardship programs and ultimately, patient care goals.
Count on MicroScan for unmatched experience, expertise, and selection.
Panel Name
Pos MIC 29
Pos MIC 34
MICroSTREP plus 1
MICroSTREP plus 2
MicroScan Catalog Number
B1017-212
B1017-216
B1027-201
B1027-202
Languages
EN,ES,FR,PT
EN,ES,FR,PT
EN,ES,FR,PT
EN,ES,FR,PT
Antimicrobic Agent
µg/mL
µg/mL
µg/mL
µg/mL
Abbr.
Antimicrobial Agent
Amoxicillin/K Clavulanate
Ampicillin
Ampicillin/Sulbactam
Azithromycin
Cefaclor
Cefazolin
Cefepime
Cefotaxime
Cefoxitin Screen
Ceftaroline
Ceftriaxone
Cefuroxime
Chloramphenicol
Ciprofloxacin
Clarithromycin
Clindamycin
Daptomycin
Erythromycin
Gatifloxacin
Gentamicin
Gentamicin Synergy Screen
Imipenem
Inducible Clindamycin Test
Levofloxacin
Linezolid
Meropenem
Moxifloxacin
Nitrofurantoin
Oxacillin
Penicillin
Rifampin
Streptomycin Synergy Screen
Synercid
Tetracycline
Tigecycline
Trimethoprim/Sulfamethoxazole
Vancomycin
µg/mL
4/2
2-8
8/4-16/8
–
–
4-16
–
–
4
–
4-32
–
8-16
1-2
–
0.25-4
0.25-4
0.25-4
–
1-8
500
4-8
4/0.5
0.5-4
0.5-4
2-8
0.5-4
32-64
0.25-2
0.03-8
1-2
1000
0.25-2
1-8
–
0.5/9.5-2/38
0.25-16
µg/mL
–
2-8
–
–
–
4-16
–
–
4
0.5-4
4-32
–
8-16
1-2
–
0.25-4
0.25-4
0.25-4
–
1-8
500
–
4/0.5
0.5-4
0.5-4
–
0.25-4
32-64
0.25-2
0.03-8
1-2
1000
0.25-2
2-8
0.12-1
0.5/9.5-2/38
0.25-16
µg/mL
0.5/0.25-4/2
0.06-4
–
0.25-2
0.5-4
–
0.25-2
0.25-2
–
–
0.25-2
0.25-2
1-16
–
–
0.06-0.5
–
0.06-0.5
0.12-2
–
–
–
–
0.25-4
–
0.06-0.5
–
–
–
0.03-4
–
–
–
0.5-4
–
0.25/4.75-2/38
0.12-1
µg/mL
0.5/0.25-4/2
0.06-4
–
0.5-2
0.5-4
–
0.25-2
0.25-2
–
–
0.25-2
0.25-2
1-16
–
0.25-1
0.06-0.5
0.25-2
0.06-0.5
–
–
–
–
–
0.25-4
0.5-4
0.06-0.5
0.25-4
–
–
0.03-4
–
–
–
0.5-4
–
0.25/4.75-2/38
0.12-4
Abbr.
Aug
Am
A/S
Azi
Cfr
Cfz
Cpe
Cft
CfxS
Cpt
Cax
Crm
C
Cp
Cla
Cd
Dap
E
Gat
Gm
GmS
Imp
ICd
Lvx
Lzd
Mer
Mxf
Fd
Ox
P
Rif
StS
Syn
Te
Tgc
T/S
Va
Total Antibiotic Tests/Panel
28
26
18
21
MicroScan Supplementary Identification Panels:
Rapid Gram Positive
B1017-166 Rapid Positive ID Type 3
Overnight Gram Positive
B1017-221 Positive ID Type 3
†Ceftaroline fosamil is sold in the United States as Teflaro® by Forest Pharmaceuticals, Inc.,
an Allergan affiliate.
‡Tigecycline is sold under the trademark name TYGACIL® by Pfizer, Inc.
1CDC, 1997. Infect. Morbid. Mortal. Weekly Rep. 46:765-766.
2Chang et al., 2003. New Engl. J. Med. 348:1342-1347.
Not all products available in all countries.
Beckman Coulter, the stylized logo and MicroScan are trademarks of Beckman Coulter, Inc. and are
registered in the USPTO.
For Beckman Coulter’s worldwide office locations and phone numbers, please visit
www.beckmancoulter.com/contact
FL-50765
© 2015 Beckman Coulter, Inc. All Rights Reserved.
www.beckmancoulter.com